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Abstract: 
Mucosal surfaces of mammals are densely colonized with microbes commonly referred to as 
the commensal microbiota. It is believed that the fetus in utero is sterile and colonization with 
microbes starts only after birth. Nevertheless, the unborn fetus is exposed to a multitude of 
metabolites originating from the commensal microbiota of the mother that reach systemic 
sites of the maternal body. The intestinal microbiota is strongly personalized and influenced 
by the environment including nutrition as one of the main shaping factors. On the other hand, 
members of the microbiota can metabolize dietary components that can reach the maternal 
host and thus the offspring. The complex interplay between nutrition and microbiota of the 
mother and its effect on offspring immunity is the basis for this Review. 
 
Introduction 
 
From the point of view of immunologists who study mammalian systems, it is easy to forget 
that viviparity (that is, the birth of live offspring) has appeared independently many times in 
the animal kingdom during evolution 1. This speaks for the clear advantages in protecting the 
developing animal to guard its nutrition, nitrogen balance, gaseous exchange and very 
existence. Mammalian evolution provides protection in early postnatal life with nutritional 
and immune support through lactation. The zenith of maternal succor has been reached in 
the eutherian mammals. These are characterized by a placenta, which serves as a highly 
adapted organ for molecular exchange between mother and fetus. Interestingly, placentation 
coevolved with epigenetic imprinting – the DNA modification system that marks certain loci 
for selective expression in the offspring, depending on whether they have been derived from 
the male or female parent. The fact that this special genetic control mechanism has evolved 
to regulate placental function and resource allocation between fetus and mother speaks to 
the delicate intimacy of having two individuals in such close contact. Despite its inevitable 
biological problems, placentation has permitted the rich molecular exchange between 
mother and fetus that has enabled the evolution of a human nervous system with advanced 
cognitive functions.  
The mammalian fetus is supported during development by the umbilical cord 2, 
through which pass almost all nutrients, respiratory gases, excretion products and 
xenobiotics. It has been recently realized that molecules from the intestinal microbiota are 
also an important part of the placental molecular exchange. After birth, the defining purpose 
of lactation is to support nutrition of the newborn. However, to an extent that varies 
depending on the mammalian species concerned, lactation also serves as a route of 
immunoglobulin, macromolecular and xenobiotic uptake and has strong effects on 
modulating the incoming microbiota of the offspring 3. 
In other words, as the placental mammal develops from one cell into an organism of 
about 1013 cells and undergoes the challenges of postnatal adaptation, it is exquisitely 
dependent on molecular exchange of different sorts with its mother. The requirement for a 
diet sufficient in calories and balanced in micronutrients (vitamins and minerals) was 
established mainly from experiments with animals in the first half of the twentieth century A 
2. The importance of maternofetal molecular exchange is generally understood by the lay 
public to be critical to healthy fetal development: pregnant women optimize their nutrition, 
avoid alcohol and (after the horrors of thalidomide-induced phocomelia) all non-essential 
medications. 
The intestinal microbiota modulates essentially all aspects of these processes and 
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contributes its own molecular signature to the tissues and the fetus of the pregnant mother. 
Indeed, the inherent microbial metagenomic diversity greatly expands the metabolic capacity 
of the host. Classical organic chemistry studies of selected molecules, modern wider-ranging 
metabolomics techniques and isotope transfer studies all show that a diverse range of 
microbial derived molecules pervasively penetrate host tissues. This Review sets out to 
examine the relative roles of nutrition and microbial metabolites in materno-fetal molecular 
exchange and how these shape healthy immune system development. The evidence will be 
mainly drawn from mouse models (because the data largely depend on our ability to 
experimentally manipulate diet and environmental factors including the colonization status). 
We will also describe the comparisons with humans in placentation, fetal development, 
postnatal lactation and immunoglobulin transfer, and hypothesize how these might affect the 
human host-microbial interactions in early life.  
 
The fetal basis for adult disease 
To emphasise how far events in fetal life shape the long-term health of the offspring, we need 
to start with the effects of maternal nutrition on development and systemic disease 4. 
Nutrition was originally shown to be a vital determinant of fetal growth and development 
from farm animal experiments dating from the first half of the last century 5 and from studies 
on humans in the tragic conditions of malnutrition in Europe at the end of the second World 
War 4.  
There is abundant evidence that nutritional and other molecular events in fetal and 
neonatal life lay a foundation for future health, including immune system function. For 
example, adult abdominal adiposity (itself predisposing to cardiovascular disease and type 2 
diabetes) is associated with prior poor intrauterine fetal growth. Lower birth weight has been 
linked to increased susceptibility in later life to osteoporosis, depression and prostate 
tumours 6-10. This epidemiological evidence implies that the adaptation to reduced nutrition 
in early life has profound long-term consequences. One mechanism for this ― discussed in 
more detail later ― is that the fetal epigenetic reprogramming that attempts to salvage fetal 
growth in the face of an inadequate macronutrient supply from the mother, persists into adult 
life when nutritional conditions are better. Malnutrition also decreases the levels of maternal 
antibody transferred to the fetus via the placental neonatal immunoglobulin receptor (FcN) 
with long term effects on disease susceptibility, B cell repertoire development, allergy and 
autoimmunity 11,12. 
The concept of a fetal basis of adult disease also extends to consumption of 
xenobiotics. The consequences of exposure to the synthetic non-steroidal estrogen 
diethylstilbestrol prescribed to pregnant women with the intention of avoiding miscarriage 
are a disastrous example of this. The consequences of diethylstilbestrol on male and female 
infertility and reproductive tract tumours only became apparent in adult life, or even in the 
next-generation offspring of those who were exposed in utero 13. These are extreme 
examples, although it should be noted that the intestinal microbiota has powerful effects on 
modulating the toxicity of many environmental and pharmaceutical xenobiotics and heavy 
metals 14,15. 
 
Maternal support of fetal immune development  
Molecular transfer of nutrients and microbial molecules in early life immune development. 
Immunity is no exception to the powerful effects of the in utero environment. Intrauterine 
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growth retardation is strongly associated with susceptibility to postnatal infectious disease 
with effects seen both in children and young adults. Malnutrition in utero impairs immune 
function through both direct and indirect mechanisms (Figure 1). For example, the loss of 
macronutrients and micronutrients directly affects leukocyte development in the fetus.  In 
addition, maternal malnutrition leads to stress responses in mother and fetus that  directly 
affect placental function and fetal immune development.  Malnutrition also leads to maternal 
immunosuppression, which decreases the availability of maternal immunoglobulin for uptake 
into the fetus and renders the mother susceptible to opportunistic or manifest infections. Any 
increase in systemic exposure to microbes will further increase the maternal stress responses 
through the hypothalamo-pituitary-adrenal (HPA) axis  16.  
There are several examples that illustrate how the direct limitation of in utero nutrient 
levels can affec immunity in neonates.  Insufficient supply of vitamin A results in impaired 
fetal differentiation of B lineage cells, including the B1a and B1b subsets that express 
antibodies that are responsible for the early phase of protection against pathogens  17. In 
addition, maternal retinoids influence the development of fetal lymphoid tissue inducer (LTi) 
cells  and subsequently the size of secondary lymphoid organs in the offspring 18. Retinoic acid 
is also required for thymic development and myeloid cell differentiation. As a final example, 
a deficient zinc supply limits the size of the thymus and spleen, and is associated with deficient 
B cell and T cell function partly because of stress-induced corticosteroids 19. 
Stress responses through the HPA axis can be generated either directly because of protein 
calorie malnutrition, or indirectly, as malnutrition leads to immunosuppression, poor 
intestinal barrier function and increased susceptibility to infection. In a healthy pregnancy, 
the fetus is protected from maternal glucocorticoid exposure because of 11-ß dehydroxylase 
activity in the placenta, which converts glucocorticoids into non-active metabolites  20, but 
malnutrition results in reduced placental dehydroxylase levels. Despite this, the effects of 
maternally delivered glucocorticoids (which suppress the fetal HPA) are much less than direct 
stimulation and activation of the fetal HPA through corticosteroids present within in the fetus. 
This has been experimentally carried out with lipopolysaccharide administration or the use of 
CpG to mimic the effects of bacterial or viral infections 16. Such manipulations have clear 
durable effects on many aspects of immunity in the offspring including reduced lymphocyte 
proliferation, antibody responsiveness and NK activity. There is also a durable resetting of the 
offspring’s HPA activity, resulting in relatively increased stress responses in later life 
(reviewed in 16). These effects are likely due to epigenetic programming: a topic that is 
discussed further below. 
Therefore, it is clear that maternal nutrition is vital for the healthy development of the 
infant immune system. This sets the scene to ask how far the microbiota (which is well known 
to increase the efficiency of energy extraction from the food 21, provide vitamins and 
metabolise xenobiotics 22) contributes to the general nutritional state in pregnancy.  
 
Effects of intestinal microbes on maternal nutrition. 
Intestinal microbes can increase the energy harvest from the diet by digesting complex 
carbohydrates (such as the constituents of plant cell walls) that are resistant to mammalian 
enzymes 21. Clearly, the microbiota cannot  itself serve as a substitute for a healthy  diet, as 
when the diet is inadequate there is insufficient energy to salvage. However, microbial 
metabolic capability is required for vitamin synthesis and to generate the short-chain fatty 
acids that sustain epithelial integrity 23 and regulatory T cell differentiation in the mother 24-
26. The evidence for this comes from specific supplementation and from studying germ-free 
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animals, which require fortified diets. This is especially true for vitamin K;  if animals that are 
raised in germ-free conditions are not supplemented with this vitamin, the synthesis of host 
clotting factors is impaired, leading to a bleeding diathesis. B group vitamins, including folate 
(also known as vitamin B9) and vitamin B12, are also synthesized by the microbiota but not 
by the host. The synthesis of these vitamins mostly occurs in the large intestine where uptake 
into the host is more restricted than in the small intestine 27.  
As maintenance of the germ-free state depends on rigorous sterilization of the food, 
normally through prolonged autoclaving of chow, the diets are generally heavily fortified with 
vitamins to avoid potential micronutrient deficiencies in the animals. Therefore, determining 
exactly where the boundaries of the microbial contribution to the maternal nutritional state 
lie requires chemically defined rigorously sterilized diets. This is not as straightforward as it 
sounds, because doses of irradiation that are used to sterilize chemically defined diets also 
reduce the vitamin availability of the diet through radiochemical effects 28. 
The proportion of micronutrients that are derived from the microbiota in mice 
depends on the extent of coprophagia [G], which is seen only in psychiatric cases in humans. 
Nevertheless, although most of the vitamins that are newly synthesized will be shed in the 
feces, there is evidence even in humans that some B12 and folate are derived from microbial 
sources 29 30. Pregnant mothers are widely supplemented with folate in developed countries 
to avoid facial clefting, neural tube and cardiac defects. Folate and B12 are relevant as the 
catalysts for methylation reactions in epigenetic marking – the relevance of this to immune 
system development will be further developed below. 
Given that intestinal motility is reduced in pregnancy through the secretion of 
progestogens, one cannot safely extrapolate physiological studies in non-pregnant 
individuals: nevertheless, it is likely that lower small intestinal microbial biomass increases in 
pregnancy and probably also the microbial-host molecular exchange of nutrients. 
 
Development of the maternofetal interface 
The basis of maternofetal contact and the organ for molecular exchange is the placenta. The 
timelines of the development of this interface and of the different phases of embryogenesis 
will be considered in terms of maternofetal molecular transfer and fetal immune 
development. 
Both mice and humans have a hemochorial placenta [G], because during the process 
of decidualization the fetal trophoblast invades both the uterine epithelium and the 
endothelium of the maternal vessels, so the syncytial cellular outer trophoblast layer is 
directly bathed with maternal blood (Figure 2A). The outer trophoblast structure has 
developed from the trophoectoderm becoming vascularized via the mesoderm of the 
allantois [G]. The allantois emerges from the posterior end of the embryo forming a vascular 
labyrinth as the trophoblast invades the mouse maternal decidua at embryonic day 12.5 
(E12.5) (Figure 2A)  31. 
As the placenta is formed, the embryonic immune system is in a phase of stem cell 
formation in the splanchnopleuric mesenchyme surrounding the developing heart, the 
aortogonadomesonephros (AGM). In the mouse at around E10.5 the phase of tissue 
migration and lineage progenitor expansion starts with lymphopoiesis in the fetal liver and 
the thymus (Figure 2B). This is aligned with the vascularization of the trophoblast and 
decidualization, yet effects of maternally derived molecules on the developing fetus can occur 
even without this intimate contact when present in sufficiently high concentration, as 
6 
 
evidenced by the teratogenic effects of a short-lived high dose of alcohol at E7 in the mouse 
32. Nevertheless, pharmacological studies of placental drug transfer indicate greater fetal 
exposure to a standardized dose at later points in gestation 33. This is inextricably linked to 
the fetal demands for oxygen and nutrients for growth: as the trophoblast area expands and 
the intrahemal distance is reduced, measurements with radioactive compounds have shown 
that both facilitated and diffusive exchange of metabolites become increased between E16 
and E19 34. 
The relationship between the fetus and the mother cannot be entirely mutualistic. 
There must be resource transfer from mother to the fetus for it to develop. Even in times of 
famine, precious resources diverted from the mother to the fetus may also be consumed by 
the trophoblast. This equilibrium is highly regulated through epigenetic imprinting, which co-
evolved with placentation. This results in placental development and increased size being 
driven by paternally expressed alleles in the fetus (e.g. insulin-like growth factor (IGF 2)), and 
counterbalanced by genes expressed from maternal alleles (e.g. IGF type 2 receptor that 
targets the protein for degradation) 35. Remarkably, most sex-specific epigenetic imprinting 
affects genes expressed in the placenta or the brain: imprinting therefore not only determines 
resource allocation between fetus and mother but also maternal endocrine responses and 
behaviour necessary to successfully nurse the offspring 36. The potential susceptibility of 
imprinting to external influences in humans was shown in a remarkable study on babies born 
from pregnancies in Holland in the famine of the 1944-1945 winter. Even 6 decades later, 
individuals born during the famine showed less DNA methylation at the IGF2 locus, possibly 
reflecting their demand for nutrition in fetal life, compared with unexposed siblings of the 
same gender 37 (also see BOX 1). 
Although genomic imprinting is not known to have major direct effects on immune 
system development in vertebrates 38  it has  major indirect effects through regulating the 
placental interface for passage of maternal antibodies. Such antibodies  transmit maternal 
immune memory of pathogens 11 and non-pathogenic members of the microbiota to the 
neonate 39. The timing of antibody transmission from mother to offspring is variable between 
different species, but in general it is a transgenerational effect that is very sensitive to 
adequate nutrition because the physiological expense of the immune response competes 
with nutrients for maternal metabolism and fetal growth 40. Maternal antibodies can be taken 
up into the circulation and tissues of the offspring to transfer immune memory, which may 
neutralize pathogens or components of the microbiota 11. These antibodies are capable of 
limiting infectious disease during the period of neonatal immune immaturity and can shape 
the development of endogenous antibody repertoires in the offspring during early life 12. 
 
Exposure of the infant to the maternal microbiota (see also BOX 2) 
Direct in utero exposure to live organisms of the maternal microbiota. 
Although the biomasses of the host and its microbiota are rather well separated, this is not 
absolute, and very small numbers of live microbial organisms can be detected in systemic 
organ systems of the host both in animal models and in humans 41 42. During late pregnancy 
and in the immediate postnatal period, translocation of intestinal and oral microbes is 
increased in both experimental rodents and in humans 43-45. This results in microbes being 
present in the placenta and in the milk 43,46. At least for placental and fetal tissues, microbial 
numbers must be maintained at extremely low levels, otherwise the pre-term birth or 
stillbirth complications of intrauterine infection will ensue 47. Nevertheless, there is evidence 
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that these organisms contribute to the early colonization of the postnatal infant 43: they may 
also play a role in supporting the developing fetal immune system in utero, although the 
extent of this is uncertain. 
 
Exposure of the fetus and neonate to penetrant maternal microbial molecules. 
In experimental mice one can show that the development of the immune system in the fetus 
is driven by maternal microbial molecules independently of actual penetration of live 
microbes into maternal or conceptus tissues. For the most part, the effects of the microbiota 
on immune system development (as well as their effects on other organ systems) have been 
determined by comparing colonized and germ-free animals 48.  
As germ-free animals are born to a germ-free dam, and colonized animals are born to a 
colonized dam, comparing these two hygiene statuses does not provide information on the 
effects of the maternal microbiota on the development of the immune system of her pups. 
However, the effect of the maternal microbiota alone can be addressed by treating germ-free 
pregnant female mice with live Escherichia coli that lacks the synthetic pathways for the 
essential bacterial amino acids, D-alanine and diaminopimelic acid 49. This strain can be grown 
in culture by providing these amino acids as supplements, but it does not permanently 
colonise the mouse intestine as D-alanine and diaminopimelic acid are not synthesized or 
available in the host to support bacterial replication in the intestinal luminal environment. 
The big advantage of this system is that the pregnant dam returns to germ-free status before 
delivery of her pups, and so the pups themselves are germ-free. Thus, one can compare the 
immune responses in the pups born to the transiently colonized mothers with pups born to a 
control germ-free mother (Figure 3). 
The results show that, compared with control germ-free pups, germ-free pups born 
to transiently colonized dams harbour higher numbers of class 3 innate lymphoid cells (ILC3s) 
in the small intestine and have increased numbers of CD11c+F4/80+ intestinal mononuclear 
cells in both the small and large intestine 50. These effects are durable from approximately 
postnatal day 5 until at least day 60. The effects are not limited to the leukocyte populations 
as intestinal mucosal transcriptional signatures (predominantly from epithelial cells) are 
profoundly reshaped in pups born to gestationally colonized dams. In particular, intestinal 
tissues from pups show increased expression of antibacterial peptides (including C-type 
lectins of the Reg family and defensins), increased cell division and differentiation of epithelial 
cells, higher expression of mucus and ion channels, increased metabolism of dietary 
xenobiotics, bile acids and complex lipids, changes in sugar metabolism and effects on 
antibody responses (including increased expression of the polymeric immunoglobulin 
receptor that is responsible for transporting IgA through the epithelial layer into the intestinal 
lumen). Strain combination experiments showed that many of these effects are dependent 
on the transiently colonized mother expressing antibodies, implying that antibody transfer to 
the fetus and neonate enhances the gestational colonization effect 50.  
As the transiently colonizing E. coli strain is unable to replicate in vivo, it is possible to 
carry out isotope flux experiments using metabolically labelled bacteria. These experiments 
showed that there is substantial transfer of metabolites from the intestinal bacteria into the 
mother, across the placenta and into the fetus 50. Because there is a long dwell time of 
bacterial metabolites that are transferred into maternal tissues, the uptake of bacterial 
metabolites continues through to the milk. There are likely to be multiple different molecules 
that are driving the process, but one group that is transferred without secondary metabolism 
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comprises ligands for the aryl hydrocarbon receptor (AhR). Administration of an authentic 
AhR ligand (indole-3-carbinol) to pregnant female mice showed that this was sufficient to 
explain the effect of maternal intestinal bacteria on fetal ILC3 populations50. 
  Such gestational colonization effects are likely to be important in preparing the 
neonatal mammal for its own microbial colonization. Experiments showed that gestational 
colonization effects prepared the pups to have a more intact intestinal barrier and blunted 
the responsiveness of  their splenocytes to systemic challenge with 
lipopolysaccharide 50.Clearly, such experiments would be unethical and technically unfeasible 
in humans, but they provide insight into possible ways in which the maternal microbiota may 
shape the fetal immune system in humans. Although mice continue to take up IgG from the 
maternal milk through the neonatal intestine until about postnatal day 12  51, human IgG 
uptake is essentially complete via placental transfer at birth. However, most human 
transplacental IgG uptake occurs in the last month of pregnancy 52. One may speculate that 
the immaturity of intestinal function that is seen in babies born pre-term (for example, their 
increased susceptibility to inflammatory necrotizing enterocolitis as a result of enteral feeding 
53 and the relative protection afforded by feeding pre-term infants human colostrum 54,which 
does contain IgG) can be explained, at least partly, by altered exposure of the neonate to  
maternal microbial components.  
 
Postnatal lactation and the neonatal microbiota 
Earlier in this Review, we described the transgenerational transfer of immune memory from 
mother to offspring that results from  the transmission of systemic antibodies (mainly IgG) 
that can limit systemic infections. Whereas this is largely transplacental and antenatal in 
humans, in some species such as ungulates this happens postnatally through the colostrum. 
Mice are in an intermediate position with both pre-natal and postnatal phases of maternal 
antibody transfer. 
In addition to containing antibodies specific for potential pathogens, milk contains 
antibodies  induced by the maternal microbiota. These antibodies mainly comprise secretory 
IgA (SIgA) and SIgM, but also include IgG isotypes in mice, and they can  protect the immature 
mucosal surfaces of the offspring. The evidence for this originates from heterozygous 
breeding studies using scid/+ mice. When these mice were born to and nursed by scid/scid 
dams (mated with wild-type males) the heterozygous offspring induced endogenous mucosal 
SIgA early, at approximately day 15, in the face of no antibody content in the maternal milk. 
In the converse experiment, where scid/+ pups are born to and nursed by wild-type dams 
(mated with scid/scid sires) endogenous mucosal SIgA induction was delayed until after 
weaning 55. This work was later developed in the JH-/- strain that is selectively deficient for 
antibodies to confirm that; one, the milk antibody protected the offspring against the 
intestinal microbiota; two, that this was a mucosal protection effect, because parenteral 
replacement of the early phase of IgG did not affect early induction of endogenous IgA when 
the maternal milk lacked antibodies; and three, that the maternal milk antibodies prevented 
microbes from translocating to the mesenteric lymph nodes in the pups 56 (Figure 5A). 
This approach has been taken further still using crosses from the pIgR-deficient strain, 
where pIgR-/-  males were crossed with pIgR+/- females  or pIgR+/- males were crossed with 
pIgR-/- females. In both cases, heterozygous and homozygous pups were obtained from each 
cross (Figure 5B). In the cases where the dam was pIgR-deficient there was no IgA or IgM 
antibody secretion into the milk. Whether or not the pup was able to secrete endogenous 
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mucosal antibodies the maternal antibody effect both protected the pup against an 
inflammatory transcriptional signature of the intestinal mucosa and differentially shaped the 
composition of the resultant endogenous microbiota, especially reducing the long term (day 
70) proportions of Proteobacteria present 57. In mice IgG is transferred from the mother to 
her offspring via the neonatal (FcN) receptor both across the placenta and via the neonatal 
duodenum. Using a heterozygous breeding strategy for FcN [FcN-/- males crossed with 
FcN+/- females] supported by germ-free experiments and experiments with colonised mice 
deficient for all antibody isotypes or selectively for IgA, it was shown that the postnatal uptake 
of maternal T-independent IgG2b and IgG3 antibodies limits the development of neonatal 
follicular helper T (TFH) cell and germinal center responses against intestinal microbes39. 
Therefore, although there are antimicrobial effects of other antimicrobial components 
of milk (including lactalbumin, lysozyme, lactoferrin and lactoperoxidase), secreted milk 
antibodies are protective for the neonatal intestinal mucosal surface, limiting penetration of 
the incoming intestinal microbes into systemic tissues and limiting B cell and inflammatory 
responses in the neonatal mucosa itself. This results in a less inflammatory composition of 
the microbial consortia that stably colonized the early life mouse intestine. This protective 
effect of secreted milk antibodies is independent of transgenerational Ig uptake in the 
neonatal intestine. Establishment of a healthy microbiota – which is likely coupled to 
development of the early life intestine – in this early phase of life is extremely important. In 
less developed countries, severe protein-energy malnutrition characterised by dysbiosis, 
small intestinal enteropathy and growth stunting can supervene at the time of weaning 58,59. 
A mammalian mother is preparing her offspring through the direct effects of nutrition and 
passage of immune memory, as well as the indirect effects of antibody-enhanced molecular 
exchange to stablise the earliest stages of host-microbial mutualism. 
 
Epilogue 
In this Review we have described how the intestinal microbiota and nutritional status of the 
mother interact in a number of distinct ways during pregnancy and the early life of the 
offspring. In addition to enhancing the all-important energy yield, the maternal microbiota 
assists with micronutrient provision and xenobiotic metabolism. There is rather pervasive 
penetration of maternal microbial compounds, which can reach the fetus via the placenta and 
the milk, enhanced by maternal antibody transfer. Uncoupling defined exposure of pregnant 
mice to live microbes from permanent colonization shows that there is a large spectrum of 
immune and non-immune effects of maternal microbial molecular exposure: the durability of 
these effects and the established effects of known environmental xenobiotics suggests that 
there are likely to be underlying epigenetic alterations.  
Both gestational colonization driven reprogramming of the neonate, as well as direct 
secretory antibody protection, prepare the immunologically immature intestinal mucosa for 
its own tsunami of colonization by endogenous intestinal microbes and help ensure that 
healthy consortia are formed which will protect the offspring from diseases throughout life. 
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Figure legends: 
Figure 1: Maternal stress weakens maternal and offspring immunity. Maternal stress, such 
as the exposure to lipopolysaccharide or malnutrition, induce the release of 
adenocorticotropin (ACTH) from the pituitarity gland. ACTH triggers the release of 
corticosteroids from the adrenal glands leading to suppression of the maternal immune 
system. Besides a generally weakened response of the pregnant women to infections, the 
lower rate of immunoglobulin production in the bone marrow results in less efficient transfer 
of immunoglobulins to the offspring via placenta and milk. 
 
Figure 2: Placenta development and fetal haematopoiesis A. Schematic view of murine 
placental development. Key points at embryonic day (E) 3.5, 6.0, E 8.5, E 12.5 and E18 are 
shown. Placenta development starts upon implantation of the blastocyst into the maternal 
endometrium. The outer layer of the blastocyst becomes the trophoblast, which later forms 
the outer layer of the placenta. The maternal endometrium contributes the maternal decidua 
of the placenta, which is accommodated by maternal spiral arteries guarantying the blood 
supply of the placenta. Fetal umbilical arteries form a labyrinth while invading the placenta 
to form an arterio-capillary-venous system. B. Time line of murine and human haematopoiesis 
during embryonic and fetal development. 
 
Figure 3: Model of transient gestational colonization of germ-free mice. Time-pregnant 
germ-free mice were gavaged with 1010 c.f.u. E. coli HA107 between E8 and E16 or kept germ-
free throughout pregnancy. E. coli HA107 is an auxotrophic strain harbouring mutations in 
the synthesis pathway of meso-diaminopimelic acid and of D-alanine. It can thus only survive 
in supplemented culture and colonizes a germ-free murine intestine transiently for 24-72 
hours. The pregnant dams returned to germ-free status before delivering their germ-free 
pups, which can subsequently be analysed for the effect of maternal gestational colonization 
on offspring immunity and disease susceptibility.  
 
Figure 4: Epigenetic re-programming during mammalian development. Key developmental 
steps are shown in relation to epigenetic modifications and gene expression patterns. Early 
after fertilization of the oocyte, DNA methylation is erased, enabling the expression of 
pluripotency-associated genes. Developmental genes required for the differentiation of 
specific cell types are still repressed by histone H3K27 methylation. As development 
proceeds, pluripotency-associated genes and paternal or maternal imprinted genes need to 
be silenced permanently by DNA methylation. At the same time, an increase in H3K4 
methylation and a reduction in H3K27 methylation enable the expression of developmental 
genes.  
 
Figure 5: Murine experimental models of maternal antibody deficiencies. A. The effect of 
maternal antibodies on the offspring can be studied by using antibody-deficient mice (JH-/-). 
JH+/+ males are crossed with JH-/- females to obtain antibody-sufficient (JH+/-) pups that are 
nursed by antibody-deficient (JH-/-) dams. As a control, JH-/- males are crossed with JH+/+ 
females to obtain antibody-sufficient (JH+/-) pups that are nursed by antibody-sufficient (JH+/+) 
dams. B. To distinguish between the roles of IgG antibodies that are passively transferred 
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from the mother to the offspring and of actively transferred maternal SIgA that are secreted 
into the maternal milk via the polymeric Ig receptor (pIgR), pIgR+/- males are crossed either 
with pIgR-/- (pIgR-deficient) or pIgR+/+ (pIgR-sufficient) females. The offspring of these matings 
always contain pIgR-deficient (pIgR-/-) and pIgR-sufficient (pIgR+/-) pups that can again be 
compared in regard to the role of endogenous antibody secretion. 
 
BOX 1: EPIGENETIC ENVIRONMENTAL INFLUENCES ON THE DEVELOPING FETUS. 
As illustrated for imprinting, epigenetics has a profound effect on the developing fetus. The 
maternal and paternal marks survive the genome-wide demethylation that occurs in 
embryonic somatic cells at the blastocyst stage. This leaves imprint control centres that are 
read into appropriate differential gene expression in the developing embryo (Figure 4). It also 
leaves virgin genetic territory on which the epigenetic controls can be established to 
determine the proliferative and differentiation fate of pluripotent cells. In contrast, in 
primordial germ-line cells the parental imprints are erased and re-established in a gender-
specific fashion during gamete development. The epigenetic processes are subject to external 
influences. The classical example of this is the brown Agouti (A/A) mouse, where coat colour 
of Avy/a pups born to an a/a (black) mother can be determined by methylation status of the 
retrotransposon regulatory region in the Avy gene. This methylation can be manipulated by 
supplementation with vitamins B12 and folate 60; as described above, de novo synthesis by 
members of the microbiota contributes to body stores of these dietary micronutrients even 
without coprophagia. Other known epigenetic modifiers are cigarette smoke (which in 
addition to other effects results in hypomethylation of the aryl hydrocarbon repressor gene 
61) and alcohol (which in addition to critical effects on CNS development also causes deficient 
lung development and defects in pulmonary innate immunity 62). 
The developing immune system requires phases of progenitor cell expansion and 
tissue migration and later lineage establishment and maturation. Epigenetic controls that are 
established through the different processes of methylation, histone modification and 
untranslated RNA expression are best described for lymphocyte lineage differentiation of 
different T cell subsets in the adult animal 63. The processes that guide differentiation of 
hemapoietic stem cells that characterize the lineage progenitors are emerging 64-66. It is 
reasonable to assume that the pervasive maternal gestational effect from the microbiota will 
also have an epigenetic basis because of its durability and the environmental precedents cited 
above. The details of these mechanisms are still under investigation. 
 
BOX 2: MATERNAL MICROBIOTA EFFECTS.  
Live microbial exposure of the trophoblast/placenta: Although the placenta is generally 
believed to be a sterile body organ, recent literature points towards a possible low-grade 
colonization of placental tissue with commensal bacteria. Colonization was however 
estimated to be low and sampling of human placenta without contamination is still a 
challenge that may have influenced the results. 
Endobiotic microbial molecular transfer: Metabolites or fragments of the maternal 
endogenous microbiota can reach the maternal serum and systemic sites and can thus be 
transferred to the unborn fetus via the placenta or to the newborn child through maternal 
milk. 
Nutrition: Dietary components in the maternal intestine can be further metabolized by 
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members of the intestinal microbiota and the resulting products can be absorbed by the 
maternal organism and subsequently transferred to the offspring. In addition, the maternal 
diet can influence composition or transcriptional state of the maternal intestinal microbiota 
itself.  
Xenobiotics: As with dietary components, several members of the human intestinal 
microbiota have the potential to metabolize xenobiotic chemicals originating from plant or 
pharmaceutical sources in the maternal gut and thereby alter the chemical exposure of the 
fetus. 
 
BOX 3: E. COLI AS MODEL ORGANISM FOR GESTATIONAL COLONIZATION. 
The effects of gestational colonization on the development of the neonatal immune system 
have only been performed by using the so far uniquely available reversibly colonizing 
commensal bacterium, E. coli HA107. Although E. coli is only a rare member of the murine 
intestinal microbiota, it is present within the human intestine, especially at early life 67,68. 
When we analyzed pups born to fully colonized SPF mice or mice colonized with the Altered 
Schedler Flora and compared them to the offspring born to gestationally E. coli colonized 
mothers, we observed the same alterations on the immune system of the offspring in 
comparison to pups born to untreated germ-free dams. We are currently working on 
generating other auxotrophic commensal bacterial strains that can be used for transient 
gestational colonization to corroborate our results. 
 
Glossary: 
Thalidomide: A drug primarily prescribed as a sedative or hypnotic. It was used against nausea 
and to cure morning sickness in pregnant women until it was discovered that it caused 
absence of limbs of the fetus at birth. 
Hypothalamo-pituitary-adrenal (HPA) axis: One of the major neuroendocrine systems that 
controls reactions to stress, the immune system, digestion, emotions etc. It consist of a 
complex set of feed-forward and feedback mechanisms between the hypothalamus, the 
pituitary gland and the adrenal cortex. Neuroendocrine neurons in the hypothalamus 
produce corticotropin-releasing hormone, which acts on the anterior pituitary gland that 
subsequently produces adrenocorticotropic hormone (ACTH). ACTH induces the adrenal 
gland to release glucocorticoids, such as cortisol. 
Coprophagia: Eating of feces, which is normal behavior for many animals. 
Hemochorial placenta: The type of placenta present in humans and some rodents, where 
maternal blood is in direct contact with the chorion. 
Allantois: A bag-like structure that forms part of the developing conceptus, which helps the 
embryo in nutrition and excretion. 
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